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Abstract 
Background: Hyperbilirubinemia is one of the common problems in neonates; the most effective and 
commonly used treatment method is phototherapy. The aim of this study was to investigate the effect of 
phototherapy on the calcium to urine creatinine ratio and serum level of 25-hydroxyvitamin D in icteric neonates 
hospitalized in term neonates treated with phototherapy at Amirkola Hospital in Babol in year 2018. Method: This 
study was performed on 60 term neonates (36 boys and 24 girls) with mean age of 1.24±4.88 who underwent 
phototherapy. The ratio of calcium to urine creatinine and serum levels of 25-hydroxyvitamin D was determined 
before and 72 hours after phototherapy. Findings: The results of this study showed that the mean serum level of 25-
hydroxyvitamin D in icteric neonates before phototherapy was 28.12 ng/dl and after 72 hours of phototherapy was 
26.17 ng/dl, which was significantly decreased (P=0.03). Also, the calcium to urinary creatinine ratio in the icteric 
neonates before phototherapy was 0.16 and after 72 hours phototherapy was 0.17 which significantly increased 
(P=0.03). Conclusion: Phototherapy reduces serum levels of 25-hydroxyvitamin D and increases urinary excretion 
of calcium in term neonates. 
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Introduction 
Bilirubin is one of the ultimate catabolism 
products that precipitate in the skin and mucous 
membranes of babies and causes jaundice. Jaundice or 
hyperbilirubinemia is one of the common problems of 
neonates during the first week of life and one of the 
main causes of concern for parents [1]. Jaundice affects 
60% of term neonates and 80% of preterm neonates in 
their first week of birth [2]. Although the 
pathophysiology of jaundice is similar in term and 
preterm neonates, preterm neonates are at higher risk 
for jaundice [3]. Jaundice usually occurs 2-4 days after 
birth, and lasts about one to three weeks [4]. Although 
there are different causes for neonatal jaundice, 
neonatal jaundice is usually benign and requires no 
therapeutic intervention [5]. Different ways to treat 
jaundice have been proposed, which is currently the 
most appropriate treatment for phototherapy. 
Phototherapy means lightning on the skin of 
neonates who have been overexpressed by excessive 
bilirubin. The use of this therapeutic approach has 
begun 50 years ago with the goal of preventing indirect 
neuropathic complications of indirect hyperglycemia 
[6]. Phototherapy uses light energy to make changes in 
the shape and structure of the bilirubin molecules that 
are deposited in the skin and subcutaneous tissues and 
by converting bilirubin into water-soluble isomers that 
can be excreted in the urine and feces without need for 
conjugation in the liver, it can reduce serum bilirubin 
levels [7]. The effectiveness of phototherapy depends on 
the type of light source used (ie, dose, spectral radius 
curve and penetration depth), the distance between light 
and the baby, the jaundice etiology, and total serum 
bilirubin level at the onset of phototherapy [8].  
Vitamin D is a unique and essential 
micronutrient whose main function is to maintain 
calcium homeostasis and bone health. Physiologically, 
there are two active forms of vitamin D, both called 
calciferol, known as vitamins D2 and D3. Vitamin D 
deficiency can interfere with calcium metabolism and 
reduce serum calcium levels (hypocalcaemia) [9]. To 
detect the deficiency of this vitamin, 25-hydroxyvitamin 
D is a benchmark. 25OHD level is a good way to 
estimate the presence of vitamin D [10]. Reducing 
serum calcium that occurs as a result of vitamin D 
reductions is one of the harmful effects of phototherapy 
on children, although the exact mechanism is still 
unclear. The wavelength of vitamin D photo 
biosynthesis is between 280 and 320 nm. In this 
wavelength, 25-hydroxyvitamin D is converted to active 
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form of vitamin D (D3). Adult studies have shown that 
higher wavelengths (110-300 nm) also trigger D3 
production [11]. Conventional phototherapy devices 
used to treat neonatal jaundice may emit radiation above 
the visible spectrum (400-710 nm) [12] and although the 
Plexiglas protector in these devices is effective in 
controlling the amount of ultraviolet radiation (that is, 
less than 400 nm), there is evidence that the amount of 
ultraviolet radiation emitted by these devices cannot be 
ignored [13]. However, few studies have been done on 
the effects of phototherapy on serum levels of 25-
hydroxyvitamin D in neonates [14].  
Therefore, this study was designed to investigate the 
effect of phototherapy on serum level of 25-
hydroxyvitamin D and calcium excretion (colosire) in 
icteric neonates hospitalized at Amirkola Hospital in 
Babol in year 2018. 
 
Research hypothesis 
Phototherapy can change the serum levels of 25-
hydroxyvitamin D and calcium in the icteric neonates. 
 
Research background 
Barak et al. (2014) examined the effect of 
phototherapy on serum levels of total calcium and 25-
hydroxyvitamin D in neonates with jaundice. This study 
was performed on 100 neonates (57 boys and 43 girls) 
with exacerbated physiologic jaundice. The level of 
vitamin D in neonates at 0, 24, 48 and 72 hours were 
9.34, 9.52, 10.22 and 10.5 ng/dl, respectively, which was 
an insignificant increase. This study showed that 
phototherapy cannot significantly reduce vitamin D in 
neonates [15]. 
Mutlu et al. (2013) studied the relationship 
between vitamin D and Hyperbilirubinemia in neonatal 
blood. The results showed that reduction of serum 
vitamin D could result in a significant increase in 
bilirubin in the blood and in the production of jaundice. 
In this experiment, the effect of phototherapy on the 
amount of vitamin D was not reported [16]. 
Mashal Khan and colleagues evaluated the 
incidence of hypocalcemia in 2016 in neonates exposed 
to jaundice under phototherapy in Karachi. This study 
was performed on 123 neonates with an average age of 8 
days, and it was determined that 22.76% of neonates 
under phototherapy had hypocalcemia after 
phototherapy, indicating a significant effect of 
phototherapy on calcium in the body of neonates [17]. 
Bahbah et al. (2015) measured the effect of 
phototherapy on serum calcium levels in neonates with 
jaundice. 50 neonates (25 girls and 25 boys) under 
phototherapy were enrolled. After examining the levels 
of calcium before and after phototherapy, it was 
concluded that phototherapy has a significant effect on 
the reduction of calcium levels in the icter neonates, and 
hypocalcemia is one of the complications of 
phototherapy [18]. 
 
Research method 
This study was interventional and quasi-
experimental. The newly born neonates of the term 
hospitalized to the Amirkola hospital of Babol after the 
first 72 hours of birth in 2018; who were selected for 
phototherapy in the neonatal department due to 
jaundice.  
 
Admission criteria 
Neonates born hospitalized due to neonatal icter 
after the third day of birth with total bilirubin more than 
15 mg/dl, weight over 2500 grams, infant feeding only 
with breast milk and not receiving probiotic or vitamin 
A + D on day 5 on routine. 
 
Exit criteria 
ABO incompatibility, G6PD deficiency, sepsis, 
congenital malformation, neonate replacement, use of 
phenobarbital in mother and baby, mother with 
hypercalcemia or hypoxemia or hypo or 
hyperparathyroidism, symptomatic racism in mother, 
use of any drug containing calcium and vitamin D by 
the mother, bone marrow in the mother, bilirubin 
directly above 1 mg/dl, and heart-liver disease were 
excluded. 
A total of 60 neonates with jaundice were 
enrolled. The neonates were healthy and physically free 
of hats or other hides. Neonatal characteristics including 
age, weight, gender and neonatal bilirubin levels were 
recorded in information forms. From these neonatal, 2 
cc blood sample was taken before phototherapy, and 
then phototherapy was started on the basis of the 
internal protocol by a conventional phototherapy device 
(8 lamps manufactured by David Company, China 40 
Watts, with light blue wavelengths of 410-470 nm) that 
were placed 20 cm from of the neonate’s body, and 
blood samples were taken again 72 hours after the start 
of phototherapy. Sampling time was about two hours 
after breastfeeding. Then, 25-hydroxyvitamin D levels 
were measured at two sections before and after the 
intervention with a special 25-hydroxyvitamin D kit 
manufactured in Iran, by Ideal Company. The ratio of 
calcium to urine creatinine was measured before and 
after phototherapy in the laboratory of Amirkola 
Hospital. 
 
Table 1: Total bilirubin serum (mg/dl) 
 
 
Note: Risk factors include sepsis, incompatibility of 
blood groups, G6PD deficiency, asphyxia, hemolysis, 
and hypopalbuminemia. These criteria are valid for after 
72 hours. 
Data were collected by a demographic 
questionnaire and serum levels of 25-hydroxyvitamin D 
and calcium and creatinine administration levels. Data 
was analyzed using SPSS V.24 software and Paired 
sample t tests were used. P value less than 0.05 was 
considered significant. 
 
 
Gesta-
tional 
age 
Photo-
therap
y 
Exchange of blood Inter-
rupting  
photo-
therap
y 
*Without 
factor 
risk 
With 
Factor 
Risk 
Term 15 25 20 10 
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Findings 
In this study, 60 neonates, 24 girls (40%) and 36 boys (60%) were treated with phototherapy with a mean ± SD 
of 1.24±4.88 days.  
 
Table 2: The serum levels of 25-hydroxyvitamin D and calcium to urine random creatinine ratios in icteric 
neonates (n = 60)
 
 
The mean serum levels of 25-hydroxyvitamin D in neonates before and after phototherapy were 28.12 ng/dl 
and after phototherapy were 26.17 ng/dl, as well as the ratio of calcium to urinary creatinine in icteric neonates 
before phototherapy was 0.16 and after phototherapy was 0.17. 
 
 
Graph 1: Serum level of 25-hydroxyvitamin D in icteric neonates before and after phototherapy 
 
The results of this study showed that serum levels of 25-hydroxyvitamin D in the icteric neonates decreased 
significantly after phototherapy than before (P=0.03, t=2.17) 
 
Graph 2: The ratio of calcium to urine random creatinine in the icteric neonates before and after 
phototherapy 
 
The results of this study showed that the ratio of calcium to urine random creatinine in the icteric neonates 
after phototherapy was significantly higher than before (P=0.03, t=-2.26). In the study of calcium to urinary 
creatinine ratios with a 0.8-value as hypercalciuria, this ratio was more than 0.8 in one of the neonates after 
phototherapy treatment. 
Variable Before phototherapy After phototherapy P value 
Serum levels of 25-
hydroxyvitamin D (ng/dl) 
14.07±28.12  15.98±26.17 0.03 
The ratio of calcium to 
urine creatinine 
0.17±0.16 0.22±0.17 0.03 
Published online in http://ijam. co. in 
160 
International Journal of Ayurvedic Medicine, 2019, 10(2), 157-161 
ISSN: 0976-5921 
 
Discussion 
The results of this study showed that phototherapy 
in hyperbilirubinemia in neonates caused a significant 
decrease in serum levels of 25-hydroxyvitamin D and a 
significant increase in calcium urinary excretion after 
phototherapy than before phototherapy. Hypocalcemia 
is one of the unusual consequences of phototherapy. The 
exact mechanism for the creation of hypocalcemia 
following phototherapy has not yet been determined 
[19]. 
The results of this study showed a significant 
reduction in serum levels of 25-hydroxyvitamin D in the 
icteric neonates after phototherapy than before 
phototherapy. Unlike the current study, Arikan et al. in 
2017 did not see any significant changes in vitamin D 
levels in neonates receiving phototherapy [20]. Gillies et 
al. (1984) measured serum levels of 25-hydroxyvitamin 
D before and 48 hours after phototherapy in 33 
neonates, and did not report any significant increase in 
25-hydroxyvitamin D levels within 48 hours of 
phototherapy [21]. No significant change in the level of 
vitamin D reported in these two studies may be due to 
the small sample size of neonatal phototherapy (30 and 
33 neonates, respectively) compared to the current study 
(60 neonates). 
The results of this study showed that the ratio of 
calcium to urine random creatinine in the icteric 
neonates after phototherapy was significantly higher 
than before. Of course, considering the 0.8% for 
calcium to urinary creatinine ratio as hypercalciuria, 
only one of the neonates (1.66% of neonates) had 
hypercalciuria after phototherapy. Imani et al. In a study 
of 100 neonates with jaundice in Zahedan in this study, 
in this study, 53% of boys and 47% of girls reported a 
significant increase in urinary calcium to creatinine ratio 
24 hours after phototherapy compared to before. None 
of the neonates studied before hypercholesterolemia 
phototherapy [22]. The results of this study were in line 
with the results of Gupta et al. (2018), which reported a 
significant increase in the ratio of calcium to creatinine 
after phototherapy in term neonates [23], but it 
contradicts the study of Hooman et al. (2009), which 
reported a ratio of calcium to urine creatinine greater 
than 0.8 in 52% of neonates in 48 hours after 
phototherapy [24]. 
Because the wavelength phototherapy device 
transmits beyond the visible spectrum and the optimal 
wavelength of vitamin D synthesis, it may produce a 
temporary effect in reducing the synthesis or even 
damage to vitamin D. Since calcium excretion in 
neonates is directly related to sodium urinary rejection, 
phototherapy may increase the urinary excretion of 
sodium, which has been done in some previous studies, 
which also causes hypercalciuria.  
 
Conclusion 
The results of this study showed that termed 
neonates undergoing phototherapy are at increased risk 
of elevated calcium excretion and decreased serum 
levels of 25-hydroxyvitamin D. It is suggested that 
further studies in this field be conducted with a control 
group that does not need phototherapy and also to 
measure serum levels of vitamin D and urinary calcium 
after phototherapy is discontinued. 
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